Global Antacids Market
Antacids Market

Report ID: SQMIG35H2402

sales@skyquestt.com
USA +1 351-333-4748

Antacids Market Size, Share, and Growth Analysis

Global Antacids Market

Antacids Market By Type (Calcium Carbonate, Magnesium Hydroxide), By Formulation (Tablets, Liquid / Suspension), By Distribution Channel, By End User, By Region - Industry Forecast 2026-2033


Report ID: SQMIG35H2402 | Region: Global | Published Date: December, 2025
Pages: 171 |Tables: 61 |Figures: 72

Format - word format excel data power point presentation

Antacids Market Insights

Global Antacids Market size was valued at USD 10.2 billion in 2024 and is poised to grow from USD 10.77 billion in 2025 to USD 16.66 billion by 2033, growing at a CAGR of 5.6% during the forecast period (2026-2033). 

Increased awareness of GERD is expected to boost market growth. Other factors include the increasing availability and availability of over the counter (OTC) antidiabetic medications that provide rapid and the effective relief from these symptoms. The increasing number of elderly people who are more susceptible to access and demand for dietary information. Changes in eating habits and lifestyle factors such as stress, smoking, alcohol consumption and obesity leading to acid related diseases may also affect the growth of the market.

Acid problems in the elderly population present a unique challenge for general practitioners and the gastrointestinal tract. Furthermore, such patients are more likely to develop disease-indicating diseases such as Barrett’s esophagus and esophageal cancer. Various combinations of therapies are used to treat such problems, and the use of antacids has increased significantly in such cases, which is expected to boost the growth of the market. There has been a steady growth in the antacids market, mainly due to rising gastrointestinal disorders such as gastroesophageal reflux (GERD), indigestion, heartburn and increasing demand for relief of acid. The use of over the counter (OTC) products is a major trend, as consumers seek quick and easy relief from heartburn and periodic indigestion, without the need for a prescription.

Market snapshot - 2026-2033

Global Market Size

USD 7.23 Billion

Largest Segment

Tablet

Fastest Growth

Liquid

Growth Rate

3.30% CAGR

Global Antacids Market ($ Bn)
Country Share for North America Region (%)

To get more insights on this market click here to Request a Free Sample Report

Antacids Market Segments Analysis

Global Antacids Market is segmented by Type, Formulation, Distribution Channel, End User and region. Based on Type, the market is segmented into Calcium Carbonate, Magnesium Hydroxide, Aluminum Hydroxide, Sodium Bicarbonate and Combination Antacids. Based on Formulation, the market is segmented into Tablets, Liquid / Suspension, Powder, Effervescent Granules and Gummies / Others. Based on Distribution Channel, the market is segmented into Retail Pharmacies, Hospital Pharmacies, Online Pharmacies / E-Commerce, Supermarkets / Hypermarkets and Clinics & Healthcare Centers. Based on End User, the market is segmented into Adults, Geriatric Population, Pediatric Use and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.  

Why is the Retail Pharmacy Channel Leading the Antacids Market?

As per global antacids market analysis, the retail pharmacy channel is the largest contributor to the antacids market, in part because retail pharmacy channels have high accessibility to consumers and are a more common consumer preferred option for purchasing over the counter (OTC) medications. Convenience, the familiarity of established brands, and access to pharmacist support, makes it a common option for those suffering from heartburn or acid reflux. Also, retail pharmacies are more likely to offer a wider variety of established brands and formulations, in turn increasing their market share.

 

The online pharmacy channel is growing the fastest. Growth in e-commerce, consumers becoming more comfortable buying medications online, and home delivery exacerbate the growth. Patients needing privacy, or are from communities with little access to retail pharmacy, increasingly depend on online pharmacies.

Why do Tablets Dominate the Antacids Market?

As per global antacids market outlook, the tablet segment leads the market due to its convenience, stability, and cost-effectiveness. Tablets have long shelf lives, are relatively easy to transport, and are the most well-accepted dosage form among consumers. Tablets can also be provided in chewable or rapidly dissolving dosage forms to enhance consumers’ interest in immediate relief from acid-based ailments.

As per global antacids market forecast, the liquid segment is the fastest growing dosage form. This growth is in part from consumer preference for dosage forms that provide quick actions, and also because of children and older adults sometimes having difficulty swallowing pills. Liquids can coat the stomach lining in a better fashion and provide more rapid relief from heartburn or indigestion. The growing popularity of liquid antacids has also been fueled by product improvements, such as flavored formulations, and sugar-free or alternative sweetener summaries.

Global Antacids Market By Dosage Form (%)

To get detailed segments analysis, Request a Free Sample Report

Antacids Market Regional Insights

Which Region Dominates the North America Antacids Market?

As per industry analysis, North America is a prominent antacids market, driven by high awareness of digestive health, established healthcare infrastructure, and widespread availability of over-the-counter (OTC) medications. The antacids market in North America is driven by high awareness of digestive health, access to several established healthcare infrastructures, and the ready availability of OTC (over-the-counter) medications. Many of the growing consumer preferences among this region focus on more accessible and convenient options for heartburn and acid reflux.

Antacids Market in the US

 

The USA is one the biggest contender in the North American antacids market. With high consumer prevalence of gastrointestinal disorders, an increased geriatric population and a dominant existing presence of original established pharmaceutical brands in the market, the USA contributes heavily. OTC antacids are popular off retail pharmacies and online stores.

Antacids Market in Canada

Canada's antacids market has steadily grown, and consumer awareness is high regarding digestive health and what market options are available. The access to OTC medications is plentiful and consumer preference is looking more towards online pharmacies and retail chains. Increasingly, consumer preference is looking for quick-relief, convenient options.

Which Country Drives Growth in the Asia-Pacific Antacids Market?

Asia-Pacific is demonstrating significant advancement potential in this market, notably due to evolving dietary habits, the rising prevalence of digestive disorders, and increasing awareness of health and wellness products.

Antacids Market in Japan

As per regional outlook, Japan is a significant contributor to Asia-Pacific antacids market. An aging population and high rates of gastrointestinal problems are driving market demand. Japanese consumers lean toward established brands and are comfortable with both tablet and liquid formulations.

Antacids Market in South Korea

As per regional forecast, South Korea's antacids market is moving quickly. Urban lifestyles, a high rate of consumption of processed and spicy foods, and adoption of OTC antacids are all contributing factors to market growth. Popularity of digital pharmacies is also rising, which is aiding easier access to antacid products.

What Region Dominates the European Antacids Market?

Europe represents a market saturation state for antacids, with demand being relatively stable due to a combination of healthcare awareness, lifestyle-related stomach complaints, and a developed distribution network of millions of retail and online pharmacies.

Antacids Market in Germany

Germany is the leading country in the European antacids market due to its strong healthcare frameworks and high healthcare consumer awareness regarding digestive health. The antacids market varies, but there is a wide selection of established antacids in the over-the-counter (OTC) market, including tablets, liquid forms, and effervescent dosage forms.

Antacids Market in the U.K.

The U.K. market has been growing steadily due to a rise in acid reflux and heartburn and an increase in use of OTC products among consumers. Distribution to the consumer comes from well-known retail pharmacy chains as well as online pharmacies.

Antacids Market in Italy

Italy's antacids market is growing due to dietary habits associated with acid-related disorders and increased awareness of digestive health. A range of dosage forms has been developed, but tablets remain the most popular. Liquid antacids are less frequently used, however there is an increased awareness since liquid antacids can provide quick relief.

Global Antacids Market By Geography
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Antacids Market Dynamics

Antacids Market Drivers

Rise in the Gastroesophageal Reflux Disease (Gerd) and its Associated Problems

  • The major factor driving the antacids market is the rise in gastrointestinal disorders, especially gastroesophageal reflux disease (GERD), acid dyspepsia and heart disease. Lifestyle changes, such as poor diet, excessive alcohol consumption, increased smoking and obesity rates contribute to these conditions. The increasing consumption of fatty, spicy and processed foods is also associated with an increased incidence of acid reflux and GERD if the demand for over the counter (OTC) antacids to provide rapid relief from symptoms is high.

Easy Availability of Over-the-Counter Antacid Products

  • Another major factor is the ubiquity and easy availability of over-the-counter antacids. Consumers prefer antacids because they are convenient, affordable, and reduce symptoms such as heartburn, acid reflux, and indigestion because retail pharmacies, e-commerce programs, and direct-to-consumer marketing channels, more people have access to antacids. weakened, especially in emerging markets. There has additionally been an upward push in self-medication amongst individuals seeking quick remedy from the minor belly issues, which has caused OTC antacids giving the marketplace considerable enhancement.

Antacids Market Restraints

Side Effects and Long-Term Health Risks Associated with Antacid Use

  • Antacids provide instantaneous relief from acidity and heartburn; however, prolonged or immoderate use will have detrimental fitness consequences. Common side effects include nausea, vomiting, and changes in magnesium levels. Long-term use of antacids, especially those containing aluminum and magnesium, is associated with risks such as kidney failure and calcium deficiency. These possible adverse effects raise concerns among healthcare professionals and patients, resulting in prolonged use of antacids and proton pump inhibitors (PPIs) or H2-increased for consumers to push new treatments.

Rising Preference for Alternative Treatments

  • The increasing popularity of new therapies such as herbal remedies and dietary modifications poses a challenge to the antacids market. More and more consumers are looking for non-drug ways to manage acid reflux and GERD symptoms, including lifestyle changes, probiotics and homeopathic solutions. As well as the root causes of stomach problems for long-term treatment targeting underlying issues such as PPIs have increased demand and H2 inhibitors. These prescription medication alternatives often provide more lasting relief than antacids, and close antacids to the limit of potential market share.

Request Free Customization of this report to help us to meet your business objectives.

Antacids Market Competitive Landscape

The global antiacids industry is highly competitive with many established players and emerging companies competing for market share. The competition comes from factors such as product innovation, strategy, pricing system, and distribution networks. Major pharmaceutical and consumer health companies dominate the market, using their extensive research and development capabilities, extensive distribution channels and strong brand recognition to maintain their market position.

The global antacids market is growing steadily, due in part to an increase in gastrointestinal disorders such as gastroesophageal reflux disease (GERD), heartburn, and indigestion, and a growing aging population more susceptible to digestive illnesses. Increased knowledge of digestive health, along with the availability of over the counter (OTC) antacids, has also supported the growth of this market.

Wonderbelly: Founded in 2022 by the brothers Noah and Lucas Kraft, Wonderbelly is a startup in the U.S. focused on developing natural, non-GMO antacids. Their products are free from talc, dye, and other synthetic materials, and they aim to provide a cleaner alternative to traditional antacids. Wonderbelly was featured on a prominent list after Zantac was recalled in 2020, and the recall and the resulting media coverage caused people to rethink the use of over-the-counter heartburn medications. Wonderbelly's products are now in stores, such as Target, and the company has developed a mobile app to help people understand their gut health as well.

Tiny Health: Founded in 2020 by Cheryl Sew Hoy, Tiny Health is a health tech company based in Austin, Texas. While not antacids specifically, the company has microbiome testing services which are one of the close cousins of gut health, another cause of digestive illness, other than heartburn and acid reflux. Their at-home tests utilize advanced sequencing tests to get microbiome composition, which would help people better understand what is causing their digestive symptoms.

Top Player’s Company Profiles

  • GlaxoSmithKline plc 
  • Pfizer Inc. 
  • Sanofi 
  • Bayer AG 
  • Johnson & Johnson 
  • Takeda Pharmaceutical Company 
  • Novartis AG 
  • AstraZeneca 
  • Dr. Reddy’s Laboratories 
  • Mylan (Viatris) 
  • Teva Pharmaceutical Industries 
  • Pfizer Consumer Healthcare 
  • Boehringer Ingelheim 
  • Abbott Laboratories 
  • Sandoz (Novartis) 
  • Sun Pharmaceutical Industries 
  • Zydus Cadila 
  • Glaxo Wellcome (GSK group) 
  • Prestige Consumer Healthcare 
  • Perrigo Company 

Recent Developments in Antacids Market

  • June 2025: The FDA published draft guidance permitting simple OTC monograph change that gave manufacturers the liberty to change their product from tablet to chewable or film without separate orders and to accelerate the speed of reformulations.
  • April 2025: GSK entered into a USD 2.2 billion mediation settlement to resolve 93% of litigation concerning Zantac and reduce surrounding legal risk clouds and uncertainties for the total antacids category.
  • April 2025: Sebela Pharmaceuticals announced favorable Phase 3 study results for tegoprazan, a P-CAB that demonstrated to be statistically superior to lansoprazole, with a planned FDA submission for Q4 2025.

Antacids Key Market Trends

Antacids Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research. 

According to SkyQuest analysis, the antacids market is driven by the increasing incidence of gastrointestinal disorders such as GERD, heartburn, malnutrition, mainly due to lifestyle factors such as nutrition and obesity. The market benefits from widespread availability of antacids, discontinuing drugs through brick-and-mortar pharmacies and online platforms. However, the market faces challenges from side effects associated with long-term antacid use and growing preference for alternative therapies to provide lasting relief. Key features are as popular sweet tasting antacids, widespread e-commerce platforms reshaping the market thereby providing the consumers with more convenient and attractive product options.

Report Metric Details
Market size value in 2024 USD 10.2 billion
Market size value in 2033 USD 16.66 billion
Growth Rate 5.6%
Base year 2024
Forecast period 2026-2033
Forecast Unit (Value) USD Billion
Segments covered
  • Type
    • Calcium Carbonate
    • Magnesium Hydroxide
    • Aluminum Hydroxide
    • Sodium Bicarbonate
    • Combination Antacids
  • Formulation
    • Tablets
    • Liquid / Suspension
    • Powder
    • Effervescent Granules
    • Gummies / Others
  • Distribution Channel
    • Retail Pharmacies
    • Hospital Pharmacies
    • Online Pharmacies / E-Commerce
    • Supermarkets / Hypermarkets
    • Clinics & Healthcare Centers
  • End User
    • Adults
    • Geriatric Population
    • Pediatric Use
    • Others
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • GlaxoSmithKline plc 
  • Pfizer Inc. 
  • Sanofi 
  • Bayer AG 
  • Johnson & Johnson 
  • Takeda Pharmaceutical Company 
  • Novartis AG 
  • AstraZeneca 
  • Dr. Reddy’s Laboratories 
  • Mylan (Viatris) 
  • Teva Pharmaceutical Industries 
  • Pfizer Consumer Healthcare 
  • Boehringer Ingelheim 
  • Abbott Laboratories 
  • Sandoz (Novartis) 
  • Sun Pharmaceutical Industries 
  • Zydus Cadila 
  • Glaxo Wellcome (GSK group) 
  • Prestige Consumer Healthcare 
  • Perrigo Company 
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

 

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Antacids Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Antacids Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Antacids Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Antacids Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Antacids Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Antacids Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300

REQUEST FOR SAMPLE

Please verify that you're not a robot to proceed!
Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Global Antacids Market size was valued at USD 7.23 Billion in 2023 and is poised to grow from USD 7.47 Billion in 2024 to USD 9.69 Billion by 2032, growing at a CAGR of 3.30% in the forecast period (2025-2032).

The global antiacids industry is highly competitive with many established players and emerging companies competing for market share. The competition comes from factors such as product innovation, strategy, pricing system, and distribution networks. Major pharmaceutical and consumer health companies dominate the market, using their extensive research and development capabilities, extensive distribution channels and strong brand recognition to maintain their market position. 'Sebela Pharmaceuticals', 'GSK', 'Johnson and Johnson', 'Sanofi S.A.', 'Bayer AG', 'Sun Pharmaceuticals Ltd', 'Zydus Lifesciences', 'Abbott Laboratories', 'AstraZeneca plc', 'Boehringer Ingelheim International GmbH', 'Dr. Reddy’s Laboratories Ltd.', 'GlaxoSmithKline plc', 'Pfizer Inc.', 'Procter & Gamble Company', 'Reckitt Benckiser Group PLC', 'Takeda Pharmaceutical Company Limited.', 'F. Hoffmann-La Roche Ltd'

The major factor driving the antacids market is the rise in gastrointestinal disorders, especially gastroesophageal reflux disease (GERD), acid dyspepsia and heart disease. Lifestyle changes, such as poor diet, excessive alcohol consumption, increased smoking and obesity rates contribute to these conditions. The increasing consumption of fatty, spicy and processed foods is also associated with an increased incidence of acid reflux and GERD if the demand for over the counter (OTC) antacids to provide rapid relief from symptoms is high.

Growing Popularity of Chewable and Flavored Antacid Tablets: One of the most important market trends is the growing demand for chewable and palatable antacid tablets. Traditionally, antacids were supplied in candy or liquid form, but consumer demand for more flavorful products has evolved into chewable products with a variety of flavors. These flavored products enhance the user experience by masking the often-chalky taste of anti-sugar, making it more appealing to a wider demographic, including younger consumers.

Which Region Dominates the North America Antacids Market?

AGC3x.webp
Aisin3x.webp
ASKA P Co. LTD3x.webp
BD3x.webp
BILL & MELIDA3x.webp
BOSCH3x.webp
CHUNGHWA TELECOM3x.webp
DAIKIN3x.webp
DEPARTMENT OF SCIENCE & TECHNOLOGY3x.webp
ETRI3x.webp
Fiti Testing3x.webp
GERRESHEIMER3x.webp
HENKEL3x.webp
HITACHI3x.webp
HOLISTIC MEDICAL CENTRE3x.webp
Institute for information industry3x.webp
JAXA3x.webp
JTI3x.webp
Khidi3x.webp
METHOD.3x.webp
Missul E&S3x.webp
MITSUBISHI3x.webp
MIZUHO3x.webp
NEC3x.webp
Nippon steel3x.webp
NOVARTIS3x.webp
Nttdata3x.webp
OSSTEM3x.webp
PALL3x.webp
Panasonic3x.webp
RECKITT3x.webp
Rohm3x.webp
RR KABEL3x.webp
SAMSUNG ELECTRONICS3x.webp
SEKISUI3x.webp
Sensata3x.webp
SENSEAIR3x.webp
Soft Bank Group3x.webp
SYSMEX3x.webp
TERUMO3x.webp
TOYOTA3x.webp
UNDP3x.webp
Unilever3x.webp
YAMAHA3x.webp
Yokogawa3x.webp

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Feedback From Our Clients